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ABSTRACT
Traditional Mediterranean diet has long been known to have many health benefits. The diet is associated by the low percentage
of certain types of cancers such as colorectal cancer, breast cancer, gastric cancer and prostate cancer. The main source of fats
in the Mediterranean diet is olive oil. In fact, the beneﬁcial health effects of olive oil have been attributed to its phenolic
compounds like phenolic alcohols, hydroxytyrosol (3,4-dihydroxyphenylethanol) and their secoiridoid derivatives
(oleocanthal). Several studies have shown that hydroxytyrosol and oleocanthal are able to inhibit proliferation and induce
apoptosis in different tumor cell lines. The aim of this review was to provide an overview of the effect of hydroxytyrosol and
–oleocanthal on different types of cancer.
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INTRODUCTION
Nowadays, cancers remain the main health concern in the
world.
However, the incidence of cancers is very different around
the world, but the Traditional Mediterranean Diet (DM)
has the lowest rate of certain types of cancer like colorectal
cancer, breast cancer, gastric cancer and cancer. prostate
cancer [1]. Cancer has been shown to be preventable
through healthy lifestyle choices [2]. Thus, it is better to
prevent by consuming a healthy diet than to cure after the
onset of the disease. The main source of fat in the
Mediterranean diet is olive oil [3], it presents an
antioxidant, anti-inflammatory, anti-tumor, anti-aging and
anticancer properties due to its chemical composition [4–
6]. The chemical composition of olive oil can be classified
into two categories, major and minor components. The
main components of olive oil are triglycerides, which have
a high level of monounsaturated fatty acid.Minor
components of olive oil include hydrocarbons, sterols,
aliphatic alcohols, tocopherols, pigments, and phenolic
compounds [7, 8]. The main phenols in olive oil are
phenolic alcohols, secoiridoids, lignans and flavones[9].
Variety of polyphenols may explain olive oil's valuable
benefits. The phenolic compounds in olive oil discussed in
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this review are hydroxytyrosol and oleocanthal, especially
with regard to new knowledge gained in the most recent
studies.
SEARCH METHODS
A literature search was carried out through PubMed,
google scholar and ScienceDirect databases.Articles
examining the cancer prevention benefits of phenolic
compounds isolated from olive oil were identified using
the following research keywords: ''olive oil'', ''olive oil
phenols''
''benefits for health'', ''hydroxytyrosol'',
''oleocanthal'', ''anticancer'', ''secoiridoids''.Records was
further manually selected according to topic, in particular
new finding regarding the role of hydroxytyrosol and
oleocanthal in cancer prevention (Figure1).
Records that did not meet the eligibility criteria were
excluded.
Eligibility criteria:
➢ Written in the English language.
➢ Published in peer-reviewed journal.
➢ Published from 2000 to 2020.
➢ Papers highlight the effects of Hydroxytyrosol
on cancer.
Articles investigate the effects of Oleocanthal on
cancer.
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Figure 1: Process of selection of the articles included in the mini-review.
RESULTS
The results are presented in a two-part format: Part one
included studies evaluating the effects of hydroxytyrosol
on cancer, and part two dealt with studies on the effects of
oleochantal on cancer.
Effects of hydroxytyrosol
Out of the thirteen studies, nine studies are included in the
first part, it demonstrated the anti-proliferative and
apoptotic effects of hydroxytyrosol against types of cancer
cells with different types of action.Li et al., and Lopez et
al., have revealed the anti-proliferative effects related to
cell promotion of apoptosis and cell cycle arrest by
suppression mechanism of Akt and NF-κB pathways with
p-value<0.05 [10-11]. Concerning the results of Rosignoli
et al., they have revealed the anti-proliferative activity by
cell cycle arrest in G2 / M phase and also by the ability to
suppress the Akt pathways and the nuclear factor kappa B
with a p value <0.05 [12]. Likewise, increased intracellular
reactive oxygen species ROS were found after incubation
with HT with a p-value<0.01[13]. On the other hand,
Toteda et al., have demonstrated that the anti-proliferative
activity of the different cell lines was inversely correlated
with the elimination of H2O2 from the support with a
value p <0.05[14] .

Effects of oleochantal
The second part included four studies; it has shown that
oleocanthal has anticancer activity against different types
of cancer. Pei et al., correlated the anti-proliferative and
apoptotic activities of –Oleocanthal with the inhibition of
STAT3 by decreasing the JAK1 and JAK2 activity and by
stimulating the SHP-1 activity with a p value <0.05 [15].
In addition, the results of Siddique et al., highlighted the
anti-proliferative activity of -oleocanthal combined with
lapatinib (LP).Treatments indicated a synergistic
inhibition of cell growth by reducing the activation of focal
adhesion kinase ( FAK) and paxillin (p-value <0.05) [16].
In contrast, the results of Ayoub et al., showed that oleocanthal has anti-tumor activity. It inhibited 97.06% of
tumor growth in athymic orthotopic mice with a p value
<0.05 [17]. The latest study by Legendre et al.,[18]
reported that -oleocanthal induced cell death in all cancer
cells examined in breast and prostate by inducing
lysosomal membrane permeability (PMT) and inhibition
of activity sphingomyelin acid (ASM) with a p-value
<0.05 [18].
The outcomes of these data discussed in this review are
summarized in Table 1.

Hydroxytyrosol

Table1: A summarized table regrouping studies included in this mini review.
Ref.

Cancer type

Treatments

Animal model
and control

Main Results

p-value

(Rosignoli, Fuccelli,
Vittoria Sepporta, et
al. 2016)

Breast (MDA and
MCF-7),
prostate
(LNCap and PC3)
and colon (SW480
and HCT116) cancer
cell lines
Human colon cancer
cells (Caco-2; HT29)

HT (100 µM for
24, 48, 72, 96, 120
and
144 h)

In vitro

HT inhibits the proliferation of
all cell lines.

< 0.05

HT (100–200 µM
for 8 and 48 h)

In vitro

HT produces cell cycle arrest
and promotes apoptosis.

< 0.05

(López de Las Hazas
et al. 2017)
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(Di Francesco et al.
2015)

Human colon cancer
(Caco-2) cells

HT (50 µM for 24
h)

(Zhao et al. 2014)

Human
hepatocellular
carcinoma (HepG2,
Hep3B, SK-HEP-1
and Huh-7) cells
Humain
Colon
Cancer
Cells
(DLD1)
Human
hepatocellular
carcinoma (HepG2,
Hep3B, SK-HEP-1
and Huh-7) cells
breast
cancer
cells(MCF-7)

HT (0–400 µM for
48 and 72 h)

(Toteda et al. 2017)

(Giordano
2015)

(Sun, Luo, et Liu
2014)

n=18
SpragueDawley
femelles

n=30
mice

HT(50, 100, or
200 µmol L-1) for
24 or 48 h
HT (0–400 µM for
48 and 72 h)

In vitro

HT (0.1–200 μM)
for 16 h

In vitro

Human
thyroid
carcinoma (TPC-1
and FB-2), papillary
and
follicular
(WRO) cells

HT (65–973 µM
for 24 and 48 h)

In vitro

al.

Human
hepatocarcinoma
(HepG2) cells under
tunicamycininduced ER stress

In vitro

(LeGendre, Breslin,
et Foster 2015b)

Human pancreatic
cancer
cells
(BxPC3)
Human
prostate
cancer cells (PC3)
Human
breast
cancer cells (MDAMB-231

HT or hepatic HTderived
metabolites
3-O-HT
glucuronide and 4O-HT
glucuronide (10
and 25 µM for 24
h)
prior
to
tunicamycin
treatment
(−)-Oleocanthal
(0.2–20 µM for 4,
24, 48
and 72 h)

(Li et al. 2014)

(Calahorra
2018)

et

et

al.

rats

n=6
Male nude mice

In vitro

HT up-regulates CB₁ tumor
suppressor gene via epigenetic
mechanisms.

<0.05

HT inhibited proliferation and
induced G2/M cell cycle arrest
and apoptosis in human HCC
cells.

<0.05

HT induced apoptosis in Human
Colon Cancer Cells Through
ROS Generation .
HT
Inhibited
Cholangiocarcinoma
Tumor
Growth by suppression the
activation of Akt and NF-κB
pathways
HT modulated the transcription
and translation of members of
the PGC-1α/ERRα and PGC1α/Nrf2 pathways
HT reduced thyroid cancer cells
viability by promoting apoptotic
cell death via intrinsic pathway.

< 0.01

Both metabolites glucuronide
inhibit ER stress, although they
induce a milder change in
mRNA expression levels of
both CHOP and BiP.

< 0.05

Induces cell death in cancer
cells
by
favoring
the
permeability of lysosomal
membranes

< 0.05

<0.05

<0.05

< 0.05

Oleocanthal

(−)-Oleocanthal
N=20
Five (−)-Oleocanthal inhibited the < 0.05
(10–100 ng/mL female
nude growth of HER2 positive breast
for 24,
mice used for cancer cells in vitro and in vivo.
48 and 72 h)
each group
(Ayoub et al. 2017)
(−)-Oleocanthal
n=15
female (-)-oleocanthal inhibited growth < 0.05
5 mg/kg (n=5)
mice
of BT-474, MCF-7, and T-47D
10 mg/kg (n=5)
human breast cancer cells
for six weeks
(Pei et al. 2016)
Human
(−)-oleocanthal
N=24
(-)-Oleocanthal
Inhibited < 0.05
Hepatocellular
(0–80 μM) for 24– Mice
Growth and Metastasis by
Carcinoma (Huh-7, 72 h(5–60 µM for (8 mice in each Blocking Activation of STAT3
HepG2
and 48 h in
group)
HCCLM3)
BT-474 and MCF7 cells; 10–100
µM for
24 and 48 h in T47D cells)
HT : hydroxytyrosol ; HCC : hepatocellular carcinoma ; NF-κB : nuclear factor kappa B ; BC: Breast cancer OC : (−)-Oleocanthal; HER
:Human epidermal growth factor receptor; AKT : Protein kinase B;PI3K : Phosphoinositide 3-kinase;MAPK : Mitogen-activated protein
kinase;STAT-3 :Signal transducer and activator of transcription 3; CDK-6 : Cyclin-dependent kinase-6;EGF : Epidermal growth factor; HGF
Hepatocyte growth factor ;TKIs : Tyrosine kinase inhibitors.
(Siddique
2019)

et
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al.

Human breast cancer
cells
(MDA-MB231, MCF-7 and BT474)
Human breast cancer
cells (BT-474, MCF7 and T-47D)
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DISCUSSION
Hydroxytyrosol effects on cancer
Hydroxytyrosol (3,4-dihydroxyphenylethanol) is a
phenylethyl alcohol, it occurs during the storage of extra
virgin olive oil according to the hydrolytic mechanism
which forms it from other types of phenolic compounds in
the form of secoiridoides [19] , [20] and [21] . n recent
years, a large number of studies have demonstrated the
anti-proliferative and apoptotic effects of hydroxytyrosol
against types of cancer cells with different types of action
[22]. Additionally, anti-tumor activity has been
demonstrated in vitro studies, with significant results in
colon (LDD1), cholangiocarcinoma, prostate (LNCaP and
PC3) and carcinogenic breast cells (MDA and MCF-7 )
and hepatocellular carcinogens (SK-HEP-1, Hep3b,
Hepg2 and Huh-7).
Li et al, showed that antiproliferative effects were due to
cell promotion of apoptosis and cell cycle arrest in several
cell types in hepatocellular carcinoma cells (HepG2,
Hep3B, SK-HEP-1 and Huh-7) and in cholangiocarcinoma
by the Akt and NF-κB pathway suppression mechanism
[10]. Lopez et al., correlated anti-proliferative activity
with the ability of hydroxytyrosol to block cell cycles and
promote apoptosis [11]. Recording the results of Rosignoli
et al., revealed that the anti-proliferative effects of HT
were associated with cell cycle arrest in the G2 / M phase
and also introduced apoptosis in human hepatocellular
carcinoma cells, by the ability to suppress Akt and kappa
B channels [12]. Furthermore, Rosignoli et al [12],
correlated anti-proliferative activities with the
accumulation of H2O2 in the prostate (LNCaP and PC3),
breast (MDA and MCF-7), and colon (SW480 and
HCT116) cancer cell lines, in other words,the antiproliferative activity of the different cell lines was
inversely correlated with the elimination of H2O2 from the
medium[12]. Thus, after treatment with HT ROS
generated which can play the role of a messenger capable
of inhibiting or triggering cell signaling pathways. Finally,
Toteda et al., showed that treatment with hydroxytyrosol
resulted in a reduction of thyroid cancer cells, by intrinsic,
by the death of apoptotic cells [14].
Oleocanthal effect on cancer
-Oleocanthal (OC) is a natural phenolic component of
extra-virgin olive oil (EVOO) [23] . It is one of the two
enantiomers of oleocanthal, it exhibits antioxidant, antiinflammatory, anti-tumor activities .
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Current studies demonstrated that oleocanthal had
anticancer, as well as anti-proliferative activity against
different types of cancer, such as, breast, prostate,
pancreatic and hepatocellular cancer. LeGendre et al.,
showed that OC inhibited cell cycle progression and
promotes apoptosis. In this sense, OC induced apoptotic
cell death by promoting the permeability of lysosomal
membranes.This promotion is done by inhibiting
sphingomyelin acid [18]. According to previous findings,
Siddique et al., showed that CO combined with lapatinib
(LP) treatments in BT-474 and SK-BR-3 breast cancer cell
lines indicate synergistic inhibition of cell growth by
reducing activation of focal adhesion kinase (FAK) and
paxillin [16]. Moreover Ayoub et al, [17] showed that OC
has an anti-tumor activity ,It inhibited 97.06% of tumor
growth in orthotopic athymic mice bearing BT-474.
Similarly, LeGendre et al, also reported that OC caused
cell death in all cancer cells examined in the breast and
prostate by inhibiting their proliferation by inducing
lysosomal membrane permeability (PMT) and inhibiting
the activity of acid sphingomyelin (ASM) [18].
CONCLUSION
Most recently published studies have confirmed that the
phenolic compounds in olive oil have many beneficial
health effects; they play a role in cancer prevention. It is
therefore better to prevent through a healthy diet than to
cure after the onset of the disease.
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